S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

NGM NGM Biopharmaceuticals Inc

1.54

0.00 (0.00%)

Last Updated: 11:00:00

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more NGM Biopharmaceuticals Charts.

NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more NGM Biopharmaceuticals Charts.

NGM Biopharmaceuticals Inc News

NGM Bio Announces Closing of Tender Offer
Saturday 6 April 2024 (11 months ago) • GlobeNewswire Inc.

NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting
Wednesday 20 March 2024 (12 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 12 March 2024 (12 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 March 2024 (12 months ago) • Edgar (US Regulatory)

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
Tuesday 12 March 2024 (12 months ago) • GlobeNewswire Inc.

Form SC 13E3 - Going private transaction by certain issuers
Saturday 9 March 2024 (12 months ago) • Edgar (US Regulatory)

Form SC 14D9 - Solicitation, recommendation statements
Saturday 9 March 2024 (12 months ago) • Edgar (US Regulatory)

More NGM Biopharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions